Nasal Cannula Market Size, Share & Trends Analysis Report By Type (Low Flow, High Flow), By Material (Plastic, Silicone), By End-use (Hospitals, Ambulatory Healthcare Services, Long Term Care Centers), By Region, And Segment Forecasts, 2021 - 2028

Report Overview

The global nasal cannula market size was valued at USD 6.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 5.5% from 2021 to 2028. The factor attributing extensively to the growth of the market is the rise in the prevalence of respiratory diseases worldwide. Chronic respiratory diseases accounted for one of the leading causes of morbidity with about 40% of chronic respiratory disease cases increased from 1990 to 2017, majorly due to asthma and COPD.

The growth in the healthcare expenditure by most of the countries and government initiatives under the public healthcare system for affordable healthcare and awareness are expected to promote patient footfall. In addition, the lifestyle shift, rise in smoker’s percentage, climatic conditions, and the increasing air pollution contribute majorly towards the rise in respiratory diseases further resulting in the market growth of nasal cannula.

Moreover, the current Covid-19 pandemic has further propelled the demand for nasal cannulas worldwide, the high-flow nasal cannula oxygenation therapy was recommended as a standard therapy across the U.S. by the Center for Disease Control and Prevention and the single-use nasal cannula witnessed a surge in demand.

The rising demand and adoption of the nasal cannula are addressed by the growing number of manufacturers and suppliers worldwide. The key players of the market with their wide distribution network have enabled the availability of technologically advanced products worldwide. The development in the nasal cannula as a silicone material, extra soft, latex-free, curved, and flared cannulas, to improve the comfort and flexibility, and the growing adoption of high flow nasal cannula in chronic respiratory disease treatment has expanded the scope and usage of the nasal cannula in patients of all ages. Furthermore, the growing e-commerce channel has enabled the availability of the products worldwide, including home care setting further fueling the adoption of the nasal cannula and market growth.

Type Insights

The low flow segment dominated the market and accounted for the largest revenue share of 64.4% in 2020. The adoption of low flow nasal cannula is growing in the home care, ambulatory, and long-term care settings where the patient is in a stable state and low or medium concentration is required. In addition, the low cost further propels the adoption leading to capturing of higher market share by the low flow nasal cannula.

The high flow nasal cannula segment is growing rapidly owing to the rise in adoption of high flow nasal cannula to provide respiratory support to severely ill patients and the recent developments that expand the usage of high flow nasal cannula in low-level healthcare settings or home use.

Material Insights

The plastic nasal cannula dominated the market and accounted for the largest revenue share of 86.0% in 2020 owing to the low cost and easier availability to provide more comfort and flexibility to the patients, including the long-term users. On the other hand, the silicone-made nasal cannula is gradually being adopted especially by long-term oxygen therapy patients who are allergic to plastic material, experience nasal and skin irritations, and inflammations.

End-use Insights

The hospital segment dominated the market and accounted for the largest revenue share of 46.5% in 2020 owing to the growth in the adoption of high-flow nasal cannulas for severe respiratory distress needing high flow oxygen denotes the higher market share of the hospital in the end-use segment. Furthermore, the growing geriatric population and the patients with long-term respiratory distress are expected to support the growth of the long-term care center market segment of nasal cannula.

The long-term care center segment is expected to witness significant growth in the coming years owing to growth in the geriatric population. In addition, an increasing number of patients suffering from long-term respiratory distress is also expected to drive the demand for long-term care centers.

Regional Insights

North America dominated the nasal cannula market and accounted for the largest revenue share of 41.1% in 2020 owing to the rise in the occurrence of respiratory diseases such as COPD and asthma, about 80% of health care expenditure accounts for chronic disease. In addition, the growth of local and international manufacturers facilitates the availability of products at low cost and adoption further propelling the market growth of nasal cannula in the region. On the other hand, Asia Pacific is expected to be the fastest-growing region over the forecast period owing to the high percentage prevalence of asthma and COPD among the population, and the growing geriatric population. The growing healthcare expenditure and the rise in local manufacturers further fuel the growth of the market in the region.

Key companies & Market Share Insights

The growing prevalence of respiratory diseases, rising geriatric population, and increasing adoption are the factors attributing to the market growth of global nasal cannula. Moreover, the current Covid 19 pandemic has led to high demand for nasal cannulas in most of the countries and the key players increased the production to meet the demand swiftly.

The focus on research and development and the technological advancement by the key players offers a more flexible and comfortable nasal cannula and enables the application of nasal cannula in the treatment of various indications. The wide distribution network and the growing e-commerce facility have enabled the availability of the products worldwide leading to an increase in adoption and market growth of the nasal cannula. Some of the prominent players in the nasal cannula market include:

• Allied Healthcare Products, Inc.

• Teleflex Incorporated

• Flexicare Medical Ltd.

• Vapotherm Inc.

• ResMed Inc.

• Fairmont Medical

• Fisher & Paykel Healthcare Limited

• Well Lead Medical Co. Ltd.

• Salter Labs

Nasal Cannula Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2016 to 2028. For this study, Grand View Research has segmented the global nasal cannula market based on type, material, end-use, and region:

• Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Low Flow Nasal Cannula

  • High Flow Nasal Cannula

• Material Outlook (Revenue, USD Million, 2016 - 2028)

  • Plastic

  • Silicone

• End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Hospitals

  • Ambulatory Healthcare Services

  • Long Term Care Centers

  • Others

• Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

  • Asia Pacific

    • China

    • India

    • Australia

    • Japan

  • Latin America

    • Brazil

    • Mexico

  • Middle East & Africa

    • South Africa